ChromaDex Corp. (NAGE): קפיטליזציית שוק

This daily price chart for Chromadex Corp (NAGE) illustrates the price action of an asset with a market capitalization reaching 0.20. The business relies on outsourcing the filling and encapsulation of components, focusing instead on marketing and R&D. Chromadex Corp (NAGE) dominates the field of cellular metabolism, leveraging patents to protect against dumping. Regulatory approvals and exclusive supplier agreements secure its monopoly status within the niche.

Market capitalization determines the total value of all an issuer's shares, reflecting the market's current assessment of business scale and investment attractiveness. By analyzing the capitalization volumes of Chromadex Corp (NAGE), an investor evaluates the asset's stability, which is critical for Chromadex Corp (NAGE) when scaling B2B supplies of anti-aging components against the backdrop of significant global brand promotion costs.